Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111351) titled 'Multi-omics Studies of Primary Aldosteronism' on Aug. 1.
Study Type: Observational [Patient Registry]
Primary Sponsor: Peking University First Hospital
Condition:
Primary Aldosteronism
Intervention:
Other: Without intervention
Recruitment Status: Recruiting
Date of First Enrollment: August 15, 2025
Target Sample Size: 400
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111351
Published by HT Digital Content Services with permission from Health Daily Digest....